Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Am J Obstet Gynecol MFM. 2019 Dec 17;2(1):100077. doi: 10.1016/j.ajogmf.2019.100077

Table 4.

Multivariable regression of severe neonatal morbidity by timing of antenatal corticosteroid administration

Severe neonatal morbidity* adjusted odds ratio (95% confidence interval) p-value

Timing of antenatal corticosteroid administration
  < 2 days before delivery 0.80 (0.59–1.07) 0.135
2 to <7 days before delivery 1.0 (referent) -
  7 to <14 days before delivery 1.15 (0.83–1.58) 0.404
  ≥ 14 days before delivery 1.57 (1.12–2.19) 0.009

Gestational age at delivery, per completed week 0.55 (0.53–0.58) <0.001

Male gender 1.31 (1.04–1.65) 0.022

Nulliparous mother 1.18 (0.93–1.49) 0.185

Delivery by cesarean section 1.23 (0.97–1.56) 0.092

Other factors considered in initial models but removed due to p>0.20 include preterm prelabor rupture of membranes, receipt of magnesium sulfate prior to delivery (for any indication), maternal smoking during pregnancy, black race, and suspected clinical chorioamnionitis.

*

Composite included death, severe intraventricular hemorrhage grade III or IV, periventricular leukomalacia, bronchopulmonary dysplasia, or necrotizing enterocolitis